Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2012

Open Access 01-12-2012 | Research

The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer

Authors: Ching-Wen Huang, Li-Chu Sun, Ying-Ling Shih, Hsiang-Lin Tsai, Chao-Wen Chen, Yung-Sung Yeh, Cheng-Jen Ma, Che-Jen Huang, Jaw-Yuan Wang

Published in: World Journal of Surgical Oncology | Issue 1/2012

Login to get access

Abstract

Background

Both colorectal cancer (CRC) and diabetes mellitus (DM) are important public health problems worldwide. As there are controversies about survival impact on CRC patients with preexisting DM, the purpose of the present study is to evaluate the incidence and the survival impact of preexisting DM on the long-term outcomes of patients with CRC in Taiwan.

Methods

From January 2002 to December 2008, 1,197 consecutive patients with histologically proven primary CRC, who received surgical treatment at a single institution, were enrolled. The clinicopathologic features between these patients with and without DM were retrospectively investigated. Moreover, we intended to analyze the impact of DM on overall survival (OS) and cancer-specific survival (CSS) rates.

Results

Of 1,197 CRC patients, 23.6% of patients had either a reported history of DM or were currently taking one or more diabetes-controlling medications. CRC patients with DM were significantly older than those without DM (P < 0.001), and had a higher incidence of cardiac disease and higher body mass index than those without DM (both P < 0.001). There were no significant differences in gender, tumor size, tumor location, histological type, AJCC/UICC cancer stage, vascular invasion, perineural invasion, comorbidity of pulmonary disease or renal disease, and OS, and CSS between two groups. Additionally, DM patients had a higher incidence of second malignancy than patients without DM (9.54% vs 6.01%, P = 0.040).

Conclusions

A considerably high prevalence of DM in CRC patients but no significant impact of DM on survival was observed in the single-institution retrospective study, regardless of cancer stages and tumor locations. Therefore, treatment strategies for CRC patients with DM should be the same as patients without DM.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin. 2010, 60: 277-300. 10.3322/caac.20073.CrossRefPubMed Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin. 2010, 60: 277-300. 10.3322/caac.20073.CrossRefPubMed
2.
go back to reference Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal OA, Schymura MJ, Lansdorp-Vogelaar MS, Seeff LC, Van Ballegooijen M, Goede SL, Ries LA: Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010, 116: 544-573. 10.1002/cncr.24760.PubMedCentralCrossRefPubMed Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal OA, Schymura MJ, Lansdorp-Vogelaar MS, Seeff LC, Van Ballegooijen M, Goede SL, Ries LA: Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010, 116: 544-573. 10.1002/cncr.24760.PubMedCentralCrossRefPubMed
3.
go back to reference Center MM, Jemal A, Ward E: International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009, 18: 1688-1694. 10.1158/1055-9965.EPI-09-0090.CrossRefPubMed Center MM, Jemal A, Ward E: International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009, 18: 1688-1694. 10.1158/1055-9965.EPI-09-0090.CrossRefPubMed
4.
go back to reference Umar A, Greenwald P: Alarming colorectal cancer incidence trends: a case for early detection and prevention. Cancer Epidemiol Biomarkers Prev. 2009, 18: 1672-1673. 10.1158/1055-9965.EPI-09-0320.CrossRefPubMed Umar A, Greenwald P: Alarming colorectal cancer incidence trends: a case for early detection and prevention. Cancer Epidemiol Biomarkers Prev. 2009, 18: 1672-1673. 10.1158/1055-9965.EPI-09-0320.CrossRefPubMed
7.
go back to reference El-Serag HB, Hampel H, Javadi F: The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006, 4: 369-380. 10.1016/j.cgh.2005.12.007.CrossRefPubMed El-Serag HB, Hampel H, Javadi F: The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006, 4: 369-380. 10.1016/j.cgh.2005.12.007.CrossRefPubMed
8.
go back to reference Everhart J, Wright D: Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA. 1995, 273: 1605-1609.PubMed Everhart J, Wright D: Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA. 1995, 273: 1605-1609.PubMed
9.
go back to reference Huxley R, Ansary-Moghaddam A, Berrington de González A, Barzi F, Woodward M: Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005, 92: 2076-2083. 10.1038/sj.bjc.6602619.PubMedCentralCrossRefPubMed Huxley R, Ansary-Moghaddam A, Berrington de González A, Barzi F, Woodward M: Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005, 92: 2076-2083. 10.1038/sj.bjc.6602619.PubMedCentralCrossRefPubMed
10.
go back to reference Li D, Yeung SC, Hassan MM, Konopleva M, Abbruzzese JL: Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology. 2009, 137: 482-488. 10.1053/j.gastro.2009.04.013.PubMedCentralCrossRefPubMed Li D, Yeung SC, Hassan MM, Konopleva M, Abbruzzese JL: Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology. 2009, 137: 482-488. 10.1053/j.gastro.2009.04.013.PubMedCentralCrossRefPubMed
11.
go back to reference Friberg E, Orsini N, Mantzoros CS, Wolk A: Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007, 50: 1365-1374. 10.1007/s00125-007-0681-5.CrossRefPubMed Friberg E, Orsini N, Mantzoros CS, Wolk A: Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007, 50: 1365-1374. 10.1007/s00125-007-0681-5.CrossRefPubMed
12.
go back to reference Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, Speizer FE, Giovannucci E: Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999, 91: 542-547. 10.1093/jnci/91.6.542.CrossRefPubMed Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, Speizer FE, Giovannucci E: Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999, 91: 542-547. 10.1093/jnci/91.6.542.CrossRefPubMed
13.
go back to reference Larsson SC, Orsini N, Wolk A: Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005, 97: 1679-1687. 10.1093/jnci/dji375.CrossRefPubMed Larsson SC, Orsini N, Wolk A: Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005, 97: 1679-1687. 10.1093/jnci/dji375.CrossRefPubMed
14.
go back to reference Calle EE, Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004, 4: 579-591. 10.1038/nrc1408.CrossRefPubMed Calle EE, Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004, 4: 579-591. 10.1038/nrc1408.CrossRefPubMed
15.
go back to reference Will JC, Galuska DA, Vinicor F, Calle EE: Colorectal cancer: another complication of diabetes mellitus?. Am J Epidemiol. 1998, 147: 816-825. 10.1093/oxfordjournals.aje.a009534.CrossRefPubMed Will JC, Galuska DA, Vinicor F, Calle EE: Colorectal cancer: another complication of diabetes mellitus?. Am J Epidemiol. 1998, 147: 816-825. 10.1093/oxfordjournals.aje.a009534.CrossRefPubMed
16.
go back to reference Flood A, Strayer L, Schairer C, Schatzkin A: Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control. 2010, 21: 1277-1284. 10.1007/s10552-010-9555-0.PubMedCentralCrossRefPubMed Flood A, Strayer L, Schairer C, Schatzkin A: Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control. 2010, 21: 1277-1284. 10.1007/s10552-010-9555-0.PubMedCentralCrossRefPubMed
17.
go back to reference Yang YX, Hennessy S, Lewis JD: Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol. 2005, 3: 587-594. 10.1016/S1542-3565(05)00152-7.CrossRefPubMed Yang YX, Hennessy S, Lewis JD: Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol. 2005, 3: 587-594. 10.1016/S1542-3565(05)00152-7.CrossRefPubMed
18.
go back to reference Limburg PJ, Anderson KE, Johnson TW, Jacobs DR, Lazovich D, Hong CP, Nicodemus KK, Folsom AR: Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2005, 14: 133-137.PubMed Limburg PJ, Anderson KE, Johnson TW, Jacobs DR, Lazovich D, Hong CP, Nicodemus KK, Folsom AR: Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2005, 14: 133-137.PubMed
19.
go back to reference Campbell PT, Deka A, Jacobs EJ, Newton CC, Hildebrand JS, McCullough ML, Limburg PJ, Gapstur SM: Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology. 2010, 139: 1138-1146. 10.1053/j.gastro.2010.06.072.CrossRefPubMed Campbell PT, Deka A, Jacobs EJ, Newton CC, Hildebrand JS, McCullough ML, Limburg PJ, Gapstur SM: Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology. 2010, 139: 1138-1146. 10.1053/j.gastro.2010.06.072.CrossRefPubMed
20.
go back to reference Larsson SC, Mantzoros CS, Wolk A: Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007, 121: 856-862. 10.1002/ijc.22717.CrossRefPubMed Larsson SC, Mantzoros CS, Wolk A: Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007, 121: 856-862. 10.1002/ijc.22717.CrossRefPubMed
21.
go back to reference Larsson SC, Orsini N, Brismar K, Wolk A: Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006, 49: 2819-2823. 10.1007/s00125-006-0468-0.CrossRefPubMed Larsson SC, Orsini N, Brismar K, Wolk A: Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006, 49: 2819-2823. 10.1007/s00125-006-0468-0.CrossRefPubMed
22.
go back to reference Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB, Fuchs CS: Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003, 21: 433-440. 10.1200/JCO.2003.07.125.CrossRefPubMed Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB, Fuchs CS: Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003, 21: 433-440. 10.1200/JCO.2003.07.125.CrossRefPubMed
23.
go back to reference Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ: Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004, 159: 1160-1167. 10.1093/aje/kwh161.CrossRefPubMed Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ: Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004, 159: 1160-1167. 10.1093/aje/kwh161.CrossRefPubMed
24.
go back to reference Huang YC, Lin JK, Chen WS, Chen WS, Lin TC, Yang SH, Jiang JK, Chang SC, Lan YT, Wang HS, Liu CY, Yang YW, Teng HW: Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol. 2011, 137: 211-220. 10.1007/s00432-010-0879-7.CrossRefPubMed Huang YC, Lin JK, Chen WS, Chen WS, Lin TC, Yang SH, Jiang JK, Chang SC, Lan YT, Wang HS, Liu CY, Yang YW, Teng HW: Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol. 2011, 137: 211-220. 10.1007/s00432-010-0879-7.CrossRefPubMed
25.
go back to reference Jullumstrø E, Kollind M, Lydersen S, Edna TH: Diabetes mellitus and outcomes of colorectal cancer. Acta Oncol. 2009, 48: 361-367. 10.1080/02841860802637765.CrossRefPubMed Jullumstrø E, Kollind M, Lydersen S, Edna TH: Diabetes mellitus and outcomes of colorectal cancer. Acta Oncol. 2009, 48: 361-367. 10.1080/02841860802637765.CrossRefPubMed
26.
go back to reference Edge SB, Byrd DR, Compton CC, Fritz AG: AJCC Cancer Staging Manual. 2010, Springer, New York, 7 Edge SB, Byrd DR, Compton CC, Fritz AG: AJCC Cancer Staging Manual. 2010, Springer, New York, 7
27.
go back to reference Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL: Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008, 300: 2754-2764. 10.1001/jama.2008.824.PubMedCentralCrossRefPubMed Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL: Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008, 300: 2754-2764. 10.1001/jama.2008.824.PubMedCentralCrossRefPubMed
28.
go back to reference Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL: Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care. 2010, 33: 931-939. 10.2337/dc09-1721.PubMedCentralCrossRefPubMed Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL: Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care. 2010, 33: 931-939. 10.2337/dc09-1721.PubMedCentralCrossRefPubMed
29.
go back to reference Stein KB, Snyder CF, Barone BB, Yeh HC, Peairs KS, Derr RL, Wolff AC, Brancati FL: Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci. 2010, 55: 1839-1851. 10.1007/s10620-009-0944-8.PubMedCentralCrossRefPubMed Stein KB, Snyder CF, Barone BB, Yeh HC, Peairs KS, Derr RL, Wolff AC, Brancati FL: Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci. 2010, 55: 1839-1851. 10.1007/s10620-009-0944-8.PubMedCentralCrossRefPubMed
30.
go back to reference Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y: Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg. 2002, 6: 88-94. 10.1016/S1091-255X(01)00019-1.CrossRefPubMed Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y: Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg. 2002, 6: 88-94. 10.1016/S1091-255X(01)00019-1.CrossRefPubMed
31.
go back to reference Polednak AP: Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev. 2006, 30: 466-472. 10.1016/j.cdp.2006.07.003.CrossRefPubMed Polednak AP: Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev. 2006, 30: 466-472. 10.1016/j.cdp.2006.07.003.CrossRefPubMed
32.
go back to reference Tsugawa K, Koyanagi N, Hashizume M, Akahoshi K, Wada H, Ayukawa J, Tomikawa M, Sugimachi K: Therapeutic strategy of emergency surgery for colon cancer in 71 patients over 70 years of age in Japan. Hepatogastroenterology. 2002, 49: 393-398.PubMed Tsugawa K, Koyanagi N, Hashizume M, Akahoshi K, Wada H, Ayukawa J, Tomikawa M, Sugimachi K: Therapeutic strategy of emergency surgery for colon cancer in 71 patients over 70 years of age in Japan. Hepatogastroenterology. 2002, 49: 393-398.PubMed
33.
go back to reference Chen CQ, Fang LK, Cai SR, Ma JP, Yang GX, Yang W, Zhan WH, He YL: Effects of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients. Chin Med J (Engl). 2010, 123: 3084-3088. Chen CQ, Fang LK, Cai SR, Ma JP, Yang GX, Yang W, Zhan WH, He YL: Effects of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients. Chin Med J (Engl). 2010, 123: 3084-3088.
34.
go back to reference Chiao EY, Nambi PV, Naik AD: The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer. J Cancer Surviv. 2010, 4: 381-387. 10.1007/s11764-010-0141-y.PubMedCentralCrossRefPubMed Chiao EY, Nambi PV, Naik AD: The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer. J Cancer Surviv. 2010, 4: 381-387. 10.1007/s11764-010-0141-y.PubMedCentralCrossRefPubMed
35.
go back to reference Sun LC, Chu KS, Cheng SC, Lu CY, Kuo CH, Hsieh JS, Shih YL, Chang SJ, Wang JY: Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer. 2009, 9: 288-10.1186/1471-2407-9-288.PubMedCentralCrossRefPubMed Sun LC, Chu KS, Cheng SC, Lu CY, Kuo CH, Hsieh JS, Shih YL, Chang SJ, Wang JY: Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer. 2009, 9: 288-10.1186/1471-2407-9-288.PubMedCentralCrossRefPubMed
36.
go back to reference Dixon MR, Haukoos JS, Udani SM, Naghi JJ, Arnell TD, Kumar RR, Stamos MJ: Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg. 2003, 138: 962-966. 10.1001/archsurg.138.9.962.CrossRefPubMed Dixon MR, Haukoos JS, Udani SM, Naghi JJ, Arnell TD, Kumar RR, Stamos MJ: Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg. 2003, 138: 962-966. 10.1001/archsurg.138.9.962.CrossRefPubMed
37.
go back to reference Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C: Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000, 124: 979-994.PubMed Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C: Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000, 124: 979-994.PubMed
38.
go back to reference Compton CC: Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol. 2003, 16: 376-388. 10.1097/01.MP.0000062859.46942.93.CrossRefPubMed Compton CC: Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol. 2003, 16: 376-388. 10.1097/01.MP.0000062859.46942.93.CrossRefPubMed
39.
go back to reference Meguerditchian AN, Bairati I, Lagacé R, Harel F, Kibrité A: Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma. Am J Surg. 2005, 189: 707-713. 10.1016/j.amjsurg.2005.03.012.CrossRefPubMed Meguerditchian AN, Bairati I, Lagacé R, Harel F, Kibrité A: Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma. Am J Surg. 2005, 189: 707-713. 10.1016/j.amjsurg.2005.03.012.CrossRefPubMed
40.
go back to reference Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP: American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer. 2000, 88: 1739-1757. 10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T.CrossRefPubMed Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP: American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer. 2000, 88: 1739-1757. 10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T.CrossRefPubMed
41.
go back to reference Shonka NA, Anderson JR, Panwalkar AW, Reed EC, Steen PD, Ganti AK: Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer. Med Oncol. 2006, 23: 515-519. 10.1385/MO:23:4:515.CrossRefPubMed Shonka NA, Anderson JR, Panwalkar AW, Reed EC, Steen PD, Ganti AK: Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer. Med Oncol. 2006, 23: 515-519. 10.1385/MO:23:4:515.CrossRefPubMed
42.
go back to reference Noh GY, Hwang DY, Choi YH, Lee YY: Effect of diabetes mellitus on outcomes of colorectal cancer. J Korean Soc Coloproctol. 2010, 26: 424-428. 10.3393/jksc.2010.26.6.424.PubMedCentralCrossRefPubMed Noh GY, Hwang DY, Choi YH, Lee YY: Effect of diabetes mellitus on outcomes of colorectal cancer. J Korean Soc Coloproctol. 2010, 26: 424-428. 10.3393/jksc.2010.26.6.424.PubMedCentralCrossRefPubMed
43.
go back to reference Siddiqui AA, Spechler SJ, Huerta S, Dredar S, Little BB, Cryer B: Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci. 2008, 53: 2486-2494. 10.1007/s10620-008-0264-4.CrossRefPubMed Siddiqui AA, Spechler SJ, Huerta S, Dredar S, Little BB, Cryer B: Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci. 2008, 53: 2486-2494. 10.1007/s10620-008-0264-4.CrossRefPubMed
44.
go back to reference Van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR: Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer. 2007, 120: 1986-1992. 10.1002/ijc.22532.CrossRefPubMed Van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR: Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer. 2007, 120: 1986-1992. 10.1002/ijc.22532.CrossRefPubMed
Metadata
Title
The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer
Authors
Ching-Wen Huang
Li-Chu Sun
Ying-Ling Shih
Hsiang-Lin Tsai
Chao-Wen Chen
Yung-Sung Yeh
Cheng-Jen Ma
Che-Jen Huang
Jaw-Yuan Wang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2012
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-10-76

Other articles of this Issue 1/2012

World Journal of Surgical Oncology 1/2012 Go to the issue